Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Heart Failure Reviews
Erschienen in: Heart Failure Reviews 4/2011

01.07.2011

Multimodality imaging in the assessment of myocardial viability

verfasst von: Sara L. Partington, Raymond Y. Kwong, Sharmila Dorbala

Erschienen in: Heart Failure Reviews | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of heart failure due to coronary artery disease continues to increase, and it portends a worse prognosis than non-ischemic cardiomyopathy. Revascularization improves prognosis in these high-risk patients who have evidence of viability; therefore, optimal assessment of myocardial viability remains essential. Multiple imaging modalities exist for differentiating viable myocardium from scar in territories with contractile dysfunction. Given the multiple modalities available, choosing the best modality for a specific patient can be a daunting task. In this review, the physiology of myocardial hibernation and stunning will be reviewed. All the current methods available for assessing viability including echocardiography, cardiac magnetic resonance imaging, nuclear imaging with single photon emission tomography and positron emission tomography imaging and cardiac computed tomography will be reviewed. The effectiveness of the various techniques will be compared, and the limitations of the current literature will be discussed.
Literatur
1.
Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97:282–289PubMed
2.
Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O’Connor CM (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008PubMedCrossRef
3.
4.
Rahimtoola SH (1996) Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 94:3055–3061PubMed
5.
Taegtmeyer H (2010) Tracing cardiac metabolism in vivo: one substrate at a time. J Nucl Med 51(Suppl 1):80S–87SPubMedCrossRef
6.
Bonow RO (1996) Identification of viable myocardium. Circulation 94:2674–2680PubMed
7.
Borgers M, De Nollin S, Thone F, Wouters L, Van Vaeck L, Flameng W (1993) Distribution of calcium in a subset of chronic hibernating myocardium in man. Histochem J 25:312–318PubMedCrossRef
8.
Di Carli MF, Prcevski P, Singh TP, Janisse J, Ager J, Muzik O, Vander Heide R (2000) Myocardial blood flow, function, and metabolism in repetitive stunning. J Nucl Med 41:1227–1234PubMed
9.
Cwajg JM, Cwajg E, Nagueh SF, He ZX, Qureshi U, Olmos LI, Quinones MA, Verani MS, Winters WL, Zoghbi WA (2000) End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution t1–201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 35:1152–1161PubMedCrossRef
10.
La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O (1994) Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 23:617–626PubMedCrossRef
11.
Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH (2010) Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. JACC Cardiovasc Imaging 3:121–131PubMedCrossRef
12.
Park SM, Hong SJ, Park JS, Lim SY, Ahn CM, Lim DS, Shim WJ (2010) Relationship between strain rate imaging and coronary flow reserve in assessing myocardial viability after acute myocardial infarction. Echocardiography
13.
Mollema SA, Delgado V, Bertini M, Antoni ML, Boersma E, Holman ER, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Viability assessment with global left ventricular longitudinal strain predicts recovery of left ventricular function after acute myocardial infarction. Circ Cardiovasc Imaging 3:15–23PubMedCrossRef
14.
Cornel JH, Bax JJ, Elhendy A, Maat AP, Kimman GJ, Geleijnse ML, Rambaldi R, Boersma E, Fioretti PM (1998) Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 31:1002–1010PubMedCrossRef
15.
Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32:375–410PubMedCrossRef
16.
Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, Samady H, Lindner JR (2003) Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 41:827–833PubMedCrossRef
17.
Agati L, Funaro S, Madonna M, Beradi E, Picardi MN, Vizza CD, Labbadia A, Francone M, Carbone I, Fedele F (2006) Tissue viability by contrast echocardiography. Eur J Echocardiogr 7:S22–S29CrossRef
18.
Montant P, Chenot F, Goffinet C, Poncelet A, Vancraeynest D, Pasquet A, Gerber BL, Vanoverschelde JL (2010) Detection and quantification of myocardial scars by contrast-enhanced 3D echocardiography. Circ Cardiovasc Imaging 3:415–423PubMedCrossRef
19.
Hoffmann R, Altiok E, Nowak B, Heussen N, Kuhl H, Kaiser HJ, Bull U, Hanrath P (2002) Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function. J Am Coll Cardiol 39:443–449PubMedCrossRef
20.
Hoffmann R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flachskampf FA, Hanrath P (1996) Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 27:330–336PubMedCrossRef
21.
Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R, Hetzell BC, Zoghbi WA (2008) A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease the optimize trial. JACC Cardiovasc Imaging 1:145–152PubMedCrossRef
22.
Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E (1998) Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31:1040–1048PubMedCrossRef
23.
Gotte MJ, van Rossum AC, Twisk JWR, Kuijer JPA, Marcus JT, Visser CA (2001) Quantification of regional contractile function after infarction: Strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol 37:808–817PubMedCrossRef
24.
Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002PubMed
25.
Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, Judd RM, Kim RJ (2001) Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-mb elevation. Circulation 103:2780–2783PubMedCrossRef
26.
Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105:162–167PubMedCrossRef
27.
Sievers B, Elliott MD, Hurwitz LM, Albert TS, Klem I, Rehwald WG, Parker MA, Judd RM, Kim RJ (2007) Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation 115:236–244PubMedCrossRef
28.
Rogers WJ Jr, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA, Petruolo S, Reichek N (1999) Early contrast-enhanced mri predicts late functional recovery after reperfused myocardial infarction. Circulation 99:744–750PubMed
29.
Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with t2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (dense) functional validations. Circulation 113:1865–1870PubMedCrossRef
30.
Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E, Nagel E (2004) Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109:2172–2174PubMedCrossRef
31.
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453PubMedCrossRef
32.
Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26:549–557PubMedCrossRef
33.
Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO (1990) Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323:141–146PubMedCrossRef
34.
Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli A, Piscione F, Indolfi C, Crisci T, Salvatore M, Chiariello M (1996) Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201tl tomography versus dobutamine echocardiography. Circulation 94:2712–2719PubMed
35.
Zimmermann R, Mall G, Rauch B, Zimmer G, Gabel M, Zehelein J, Bubeck B, Tillmanns H, Hagl S, Kubler W (1995) Residual 201tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation 91:1016–1021PubMed
36.
Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, He ZX, Mahmarian JJ, Verani MS (1996) Assessment of myocardial viability with 99 mtc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 94:1010–1017PubMed
37.
Knapp FF Jr, Franken P, Kropp J (1995) Cardiac spect with iodine-123-labeled fatty acids: Evaluation of myocardial viability with bmipp. J Nucl Med 36:1022–1030PubMed
38.
Leoncini M, Marcucci G, Sciagra R, Frascarelli F, Simonetti I, Bini L, Maioli M, Mennuti A, Dabizzi RP (2001) Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99 m sestamibi gated single-photon emission computed tomography and dobutamine stress. Am J Cardiol 87:1346–1350PubMedCrossRef
39.
Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA (1994) Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201tl and 99mtc-sestamibi. Circulation 89:2552–2561PubMed
40.
Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH (2001) Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26:147–186PubMedCrossRef
41.
Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A (1994) Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35:1758–1765PubMed
42.
Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ikekubo K et al (1992) Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 33:659–667PubMed
43.
Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE (2005) Metabolic imaging with beta-methyl-p-[(123)i]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112:2169–2174PubMedCrossRef
44.
Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC (2007) Clinical myocardial perfusion pet/ct. J Nucl Med 48:783–793PubMedCrossRef
45.
46.
Wolpers HG, Burchert W, van den Hoff J, Weinhardt R, Meyer GJ, Lichtlen PR (1997) Assessment of myocardial viability by use of 11c-acetate and positron emission tomography. Threshold criteria of reversible dysfunction. Circulation 95:1417–1424
47.
Lautamaki R, Schuleri KH, Sasano T, Javadi MS, Youssef A, Merrill J, Nekolla SG, Abraham MR, Lardo AC, Bengel FM (2009) Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: Evaluation in a porcine model of myocardial infarction. Circ Cardiovasc Imaging 2:299–305PubMedCrossRef
48.
Di Carli MF (2007) Myocardial viability assessment with pet and pet/ct: In cardiac pet and pet/ct imaging. Springer, New York
49.
Carrel T, Jenni R, Haubold-Reuter S, von Schulthess G, Pasic M, Turina M (1992) Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 6:479–484PubMedCrossRef
50.
Grandin C, Wijns W, Melin JA, Bol A, Robert AR, Heyndrickx GR, Michel C, Vanoverschelde JL (1995) Delineation of myocardial viability with pet. J Nucl Med 36:1543–1552PubMed
51.
Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314:884–888PubMedCrossRef
52.
Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J (1995) Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92:3436–3444PubMed
53.
Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates G, Freeman M, Nahmias C, Hendry P, Burns RJ, Lamy A, Mickleborough L, Kostuk W, Fallen E, Nichol G (2002) Positron emission tomography and recovery following revascularization (parr-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 40:1735–1743
54.
Yamaguchi A, Ino T, Adachi H, Murata S, Kamio H, Okada M, Tsuboi J (1998) Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 65:434–438PubMedCrossRef
55.
Tarakji KG, Brunken R, McCarthy PM, Al-Chekakie MO, Abdel-Latif A, Pothier CE, Blackstone EH, Lauer MS (2006) Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 113:230–237PubMedCrossRef
56.
Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD (1998) Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98:II51–II56
57.
Al-Mallah MH, Sitek A, Moore SC, Di Carli M, Dorbala S (2010) Assessment of myocardial perfusion and function with pet and pet/ct. J Nucl Cardiol 17:498–513PubMedCrossRef
58.
Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Huitink JM, Kamp O, Nijland F, Roelandt JR, Visser CA (1997) Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 30:377–383PubMedCrossRef
59.
Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Reijs AE, Boersma E, Teule GJ, Visser CA (1996) Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 spect, thallium-201 stress-reinjection spect and dobutamine echocardiography. J Am Coll Cardiol 28:558–564PubMedCrossRef
60.
Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, Huisman M, Poethko T, Schuster T, Yu M, Robinson S, Casebier D, Henke J, Wester HJ, Schwaiger M (2009) Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18f-bms-747158–02: Comparison to 13n-ammonia and validation with microspheres in a pig model. Circulation 119:2333–2342PubMedCrossRef
61.
Kuhl HP, Lipke CS, Krombach GA, Katoh M, Battenberg TF, Nowak B, Heussen N, Buecker A, Schaefer WM (2006) Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 27:846–853PubMedCrossRef
62.
Achenbach S (2007) Cardiac ct: state of the art for the detection of coronary arterial stenosis. J Cardiovasc Comput Tomogr 1:3–20PubMedCrossRef
63.
Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP, Schuleri KH, Fernandes VR, Zviman M, Nazarian S, Halperin HR, Wu KC, Hare JM, Lima JA (2006) Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 113:394–404PubMedCrossRef
64.
Brodoefel H, Klumpp B, Reimann A, Fenchel M, Heuschmid M, Miller S, Schroeder S, Claussen C, Scheule AM, Kopp AF (2007) Sixty-four-msct in the characterization of porcine acute and subacute myocardial infarction: determination of transmurality in comparison to magnetic resonance imaging and histopathology. Eur J Radiol 62:235–246PubMedCrossRef
65.
Gerber BL, Belge B, Legros GJ, Lim P, Poncelet A, Pasquet A, Gisellu G, Coche E, Vanoverschelde JL (2006) Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 113:823–833PubMedCrossRef
66.
Inaba Y, Chen JA, Bergmann SR (2010) Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: a meta-analysis. J Nucl Cardiol 17:646–654PubMedCrossRef
67.
Dilsizian V (2007) Cardiac magnetic resonance versus spect: are all noninfarct myocardial regions created equal? J Nucl Cardiol 14:9–14PubMedCrossRef
68.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39:1151–1158PubMedCrossRef
69.
Canty JM Jr, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA (2004) Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res 94:1142–1149PubMedCrossRef
Metadaten
Titel
Multimodality imaging in the assessment of myocardial viability
verfasst von
Sara L. Partington
Raymond Y. Kwong
Sharmila Dorbala
Publikationsdatum
01.07.2011
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 4/2011
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-010-9201-7

Weitere Artikel der Ausgabe 4/2011

Heart Failure Reviews 4/2011 Zur Ausgabe

Erratum

Erratum to: Resveratrol and red wine, healthy heart and longevity

OriginalPaper

Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy

OriginalPaper

Novel techniques for assessment of left ventricular systolic function

OriginalPaper

The diastolic stress test: a new approach to an old problem

OriginalPaper

The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy

OriginalPaper

The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise